Revenue and Profit - Revenue for Q3 2024 reached ¥1,445,177,821.94, an increase of 6.93% year-over-year, while year-to-date revenue was ¥4,265,122,404.12, up 10.57% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was ¥93,834,937.26, a decrease of 6.47% year-over-year, with year-to-date net profit at ¥313,951,598.45, an increase of 10.95%[2] - Basic earnings per share for Q3 2024 was ¥0.4087, down 6.45% from the previous year, while year-to-date basic earnings per share was ¥1.3673, up 10.95%[2] - Total operating revenue for the third quarter reached CNY 4,265,122,404.12, an increase of 10.6% compared to CNY 3,857,232,359.17 in the same period last year[15] - Net profit for the third quarter was CNY 308,318,284.20, compared to CNY 277,181,418.95 in the previous year, representing an increase of 11.2%[16] - Total profit for the period was CNY 371,461,032.63, an increase from CNY 318,057,011.48, representing a growth of 16.7%[16] - The basic earnings per share for the third quarter was CNY 1.3673, compared to CNY 1.2324 in the same quarter last year, reflecting an increase of 10.9%[16] Assets and Liabilities - The company's total assets as of the end of Q3 2024 were ¥8,911,788,928.88, reflecting an increase of 8.50% from the end of the previous year[2] - Current assets rose to CNY 4,132,835,852.01, up from CNY 3,731,759,847.75, indicating an increase of about 10.7%[13] - Total liabilities rose to CNY 4,279,687,683.10 from CNY 3,933,609,667.25, reflecting an increase of about 8.8%[14] - The company's equity attributable to shareholders increased to CNY 4,349,915,974.86 from CNY 4,106,981,798.93, showing a growth of approximately 5.9%[14] - The total current liabilities amounted to CNY 2,704,483,983.08, compared to CNY 2,672,521,911.30, indicating a slight increase of about 1.2%[14] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥287,537,218.63, a significant increase of 156.53% compared to the previous year[8] - Cash inflow from operating activities totaled CNY 3,472,190,897.02, an increase of 8.8% compared to CNY 3,192,844,437.49 in the previous period[17] - Cash inflow from investment activities reached CNY 610,342,436.65, a substantial increase from CNY 159,391,696.16 in the prior year[17] - Cash inflow from financing activities amounted to CNY 1,834,884,287.42, up from CNY 1,461,513,152.55 year-over-year[18] - The ending balance of cash and cash equivalents was CNY 1,048,222,105.50, compared to CNY 813,159,096.92 at the end of the previous period[18] Research and Development - Research and development expenses for Q3 2024 amounted to ¥187,775,652.96, representing a 35.73% increase compared to the same period last year[5] - Research and development expenses increased to CNY 187,775,652.96, up from CNY 138,340,539.47, marking a rise of 35.7% year-over-year[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,160[9] - Tianjin Lianlong Technology Group Co., Ltd. holds 14.14% of shares, amounting to 32,461,290 shares, with 17,606,000 shares pledged[9] - Lianlong International Group Limited owns 10.91% of shares, totaling 25,059,240 shares[9] - Tianjin Juxinlong Equity Investment Fund Partnership holds 6.87% of shares, which is 15,784,409 shares[9] - The total number of restricted shares at the beginning of the period is 15,190,577 shares, with no shares released or added during the period[12] - The company has a total of 4,931,157 shares under lock-up for executives, which will be released after performance commitments are fulfilled[12] - The top ten shareholders include both domestic and foreign entities, indicating a diverse ownership structure[11] - The employee stock ownership plan holds 4,052,367 shares, which are also under the same trading restrictions[11] Other Financial Metrics - The company reported a government subsidy of ¥5,663,040.86 in Q3 2024, contributing to a total of ¥19,521,472.66 year-to-date[3] - The company reported other income of CNY 39,878,947.06, significantly higher than CNY 16,585,263.79 from the previous year, indicating a growth of 140.5%[15] - Tax expenses for the quarter were CNY 63,142,748.43, compared to CNY 40,875,592.53, reflecting an increase of 54.5%[16] - The company experienced a net foreign exchange loss of CNY 968,332.87, contrasting with a gain of CNY 5,020,992.79 in the previous year[16]

证券代码：300596 证券简称：利安隆 公告编号：2024-049 天津利安隆新材料股份有限公司 关于 2024 年度日常关联交易预计公告 天津利安隆新材料股份有限公司（以下简称"公司"）及子公司根据日常生产经 营的需要，预计 2024 年度将与关联方河北凯德生物材料有限公司（以下简称"河北 凯德"）发生日常关联交易，总金额不超过人民币 1,800 万元，关联交易的内容为公 司及子公司向河北凯德采购原材料。2023 年度公司与河北凯德之间不存在关联关系， 故 2023 年公司及子公司与河北凯德之间的交易不构成关联交易。 2024 年 10 月 8 日，公司召开第四届董事会第十五次会议，审议通过了《关于 2024 年度日常关联交易预计的议案》，关联董事李海平先生、谢金桃女士回避表决。公司 2024 年第二次独立董事专门会议对该事项已经审议并一致同意。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： ● 本次日常关联交易事项已经公司第四届董事会第十五次会议及第四届监事会 第十四次会议审议通过，关联董事及关联监事已经回避表决。 ● 本次日常关联交易 ...

证券代码：300596 证券简称：利安隆 公告编号：2024-051 天津利安隆新材料股份有限公司（以下简称"公司"）第四届监事会第十四 次会议通知已于 2024 年 10 月 5 日以电话及电子邮件的形式发出，会议通知中包 括会议的相关资料，同时列明会议的召开时间、地点、内容和方式。会议于 2024 年 10 月 8 日上午 9:00 在公司会议室以现场方式召开，采取现场记名投票方式进 行表决。本次会议应出席监事 3 名，实际出席监事 3 名，会议由监事会主席丁欢 女士主持。本次会议的召集、召开及表决程序符合《公司法》及《公司章程》的 有关规定，合法有效。 二、 会议审议情况 天津利安隆新材料股份有限公司 第四届监事会第十四次会议决议公告 本公司及全体监事会成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 会议召开情况 1.审议通过《关于 2024 年度日常关联交易预计的议案》 经审议，监事会认为：公司预计的 2024 年度日常关联交易事项，是公司实 际生产经营需要，不存在任何内部交易，关联交易预计事项的决策、审议程序符 合《公司法》、《深圳证券交易所创业板股票上市规则》 ...

天津利安隆新材料股份有限公司（以下简称"公司"）第四届董事会第十五 次会议于 2024 年 10 月 5 日以电话及电子邮件的方式发出通知，会议通知中包括 会议的相关资料，同时列明会议的召开时间、地点、内容和方式。会议于 2024 年 10 月 8 日上午 10:00 以现场会议及通讯会议相结合方式在公司会议室召开， 采用现场投票的方式进行表决。本次会议应出席董事 11 名，实际出席董事 11 名。会议由董事长李海平先生主持，公司监事会成员及高级管理人员列席会议。 本次会议的召开和表决程序符合《公司法》等法律、法规和《公司章程》的 有关规定。 二、 会议审议情况 1.审议通过《关于 2024 年度日常关联交易预计的议案》 证券代码：300596 证券简称：利安隆 公告编号：2024-050 天津利安隆新材料股份有限公司 第四届董事会第十五次会议决议公告 本公司及全体董事会成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 会议召开情况 2024 年 10 月 8 日 经审议，董事会认为公司关联方财务及资信状况良好，具有良好的履约能力， 日常交易中均能履行合同约定，不会给公司带 ...

证券研究报告 | 公司动态点评 2024 年 09 月 20 日 利安隆（300596.SZ） 1H24 公司业绩全面改善，多元业务布局注入新动能 | --- | --- | --- | --- | --- | --- | --- | --- | |----------------------|-------|-------|-------|-------|-------|------------------------------------------|----------| | 财务指标 | 2022A | 2023A | 2024E | 2025E | 2026E | 买入（首次评级） | | | 营业收入（百万元） | 4,843 | 5,278 | 6,044 | 6,854 | 7,566 | 股票信息 | | | 增长率 yoy （ % ） | 40.6 | 9.0 | 14.5 | 13.4 | 10.4 | | | | 归母净利润（百万元） | 526 | 362 | 439 | 586 | 725 | 行业 | 基础化工 | | 增长率 yoy （ % ） | 25.9 | -31.0 ...

446 | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------|----------------------------------------|---------------------------------|----------------------------------------------| | 2024 年 09 月 07 日 \n利安隆（ 300596.SZ ） \n业绩延续改善趋势，多层次业务打造可持续发展 \n投资要点 | 投资评级 \n股价 | 基础化工 \n(2024-09-06) | 公司研究●证券研究报告 \n\| 增持 | 公司快报 \n其他化学制品Ⅲ -B(维持) \n23.90 元 | | | 交易数 ...

[Table_MainInfo] 公司研究/化工/基础化工材料制品 证券研究报告 利安隆（300596）公司半年报点评 2024 年 09 月 05 日 [Table_InvestInfo] 投资评级 优于大市 维持 | --- | --- | |------------------------------------------------------------------------|-------------| | 股票数据 | | | 09 [ Table_StockInfo 月 04 日收盘价（元） ] | 25.11 | | 52 周股价波动（元） | 18.07-35.82 | | 总股本 / 流通 A 股（百万股） | 230/214 | | 总市值 / 流通市值（百万元） | 5766/5384 | | 相关研究 | | | [Table_ReportInfo] 《 2023Q3 公 司 归 母 净 利 润 环 比 略 增 》 | | | 2023.11.26 | | 市场表现 [Table_QuoteInfo] -46.17% -37.17% -28.17% -19.17% -10.17 ...

证券代码：300596 证券简称：利安隆 公告编号：2024-048 天津利安隆新材料股份有限公司 关于控股股东部分股份解除质押的公告 重要内容提示： ●天津利安隆新材料股份有限公司（以下简称"公司"）控股股东天津利安隆科 技集团有限公司（以下简称"利安隆集团"）持有公司股份为 32,461,290 股，占公 司总股本的 14.14%，本次解除质押前累计质押股份数量为 23,056,000 股，本次解除 质押后累计质押股份数量为 17,606,000 股，占其持有公司股份总数的 54.24%，占公 司总股本的 7.67%。 ●控股股东一致行动人利安隆国际集团有限公司（以下简称"利安隆国际"）持 有公司股份为 25,059,240 股，占公司总股本的 10.91%，其中被质押的股份累计 0 股， 占其持有公司股份总数的 0.00%，占公司总股本的 0.00%。 ●截至本公告日，控股股东、实际控制人及一致行动人合计持有公司股份 57,520,530 股，占公司总股本的 25.05%。本次股东股份解除质押办理完成后，控股 股东、实际控制人及一致行动人所持公司股份中已质押的股份总数为17,606,000股， 占其所持 ...

公 司 研 究 东 兴 证 券 股 份 有 限 公 司 证 券 研 究 报 告 利安隆（300596.SZ）：业绩稳步增 长，多元化发展拓宽空间 利安隆发布 2024 年中报：公司 2024 年上半年实现营业收入 28.20 亿元， YoY+12.54%，归母净利润 2.20 亿元，YoY+20.51%。 从收入端看，核心板块营收均实现增长。2024 年上半年，公司主业高分子材 料抗老化助剂业务实现增长，抗氧化剂营收同比增长 13.81%至 8.69 亿元、光 稳定剂营收同比增长 10.62%至 10.22 亿元、U-pack 业务营收同比增长 4.95% 至 2.88 亿元；润滑油添加剂业务也取得增长，营收同比增长 26.44%至 5.21 亿元。从利润端看，2024 年上半年公司综合毛利率同比提升 2.11 个百分点至 21.41%，带动公司净利润增长。 主业产品产能持续扩张，培育多元化发展曲线，拓展成长空间。①公司主业高 分子材料抗老化助剂方面，已发展成为国内抗老化行业的龙头企业，在管理团 队、技术、产品配套、品质、客户服务及营销等各个领域形成了良好的竞争优 势。目前公司在全国建有六大生产基地，夯实了单 ...

Investment Rating - The report maintains an "Outperform" rating for the company, indicating a positive outlook compared to the market [5][6][10]. Core Views - The company's performance in the first half of 2024 met expectations, with a revenue of 2.82 billion yuan, a year-on-year increase of 12.54%, and a net profit of 220 million yuan, up 20.51% year-on-year [5][6]. - The antioxidant industry is showing signs of recovery from a low point, with the company benefiting from increased production capacity and improved product margins [5][6]. - The company is expanding its lubricant additive business, which is expected to grow alongside the global supply chain restructuring [5][6]. - A new growth curve is emerging from the company's life sciences division and electronic-grade PI materials, which are anticipated to contribute to future revenue [5][6]. Summary by Sections Financial Performance - For the first half of 2024, the company reported a revenue of 2.82 billion yuan, with a net profit of 220 million yuan, reflecting a year-on-year growth of 20.51% [5][6]. - The gross margin for antioxidants improved by 3.71 percentage points to 19.8%, while the gross margin for light stabilizers increased by 3.77 percentage points to 34.16% [5][6]. Growth Drivers - The company is set to increase production capacity with new facilities coming online, including a 60,000-ton annual antioxidant plant and a 5,500-ton light stabilizer plant [5][6]. - The life sciences division has begun to show scale, with successful trials in nucleic acid monomers and plans for further expansion into electronic-grade materials [5][6]. Profitability Forecast - The company’s net profit for 2024 is projected to be 491 million yuan, a decrease from the previous estimate of 599 million yuan, but the forecasts for 2025 and 2026 remain unchanged at 713 million yuan and 839 million yuan, respectively [5][6].